Drug administration and dosing regimens

Last updated: February 10, 2022

Drug administration and dosing regimens

PGreen

PGreen

Cell-cell junctions
Marfan syndrome
Cellular structure and function
Development of the renal system
Mitosis and meiosis
Colorectal polyps and cancer: Pathology review
Endometrial hyperplasia and cancer: Clinical
Lung cancer
Metaplasia and dysplasia
Oral cancer
Testicular cancer
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Arterial disease
Asthma
Atrial septal defect
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Angina pectoris
Aortic valve disease
Coarctation of the aorta
Heart failure
Pneumonia
Tetralogy of Fallot
Shock
Mitral valve disease
Pericarditis and pericardial effusion
Pleural effusion
Dementia: Pathology review
Dementia: Pathology review
Dementia: Pathology review
Dementia: Pathology review
Dementia: Pathology review
Anxiety disorders: Clinical
Arteriovenous malformation
Bipolar and related disorders
Cauda equina syndrome
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Panic disorder
Parkinson disease
Stroke: Clinical
Alzheimer disease
Diabetes mellitus: Pathology review
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Cushing syndrome
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Hypothyroidism
Insulin
Pelvic inflammatory disease
Testosterone
Polycystic ovary syndrome
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Thyroid hormones
Anemia of chronic disease
Chronic leukemia
Coagulation disorders: Pathology review
Disseminated intravascular coagulation
Factor V Leiden
Hemophilia
Non-Hodgkin lymphoma
Hypocalcemia
Hypokalemia
Inflammation
Innate immune system
Introduction to the immune system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Acute cholecystitis
Acute pancreatitis
Acute pyelonephritis
Alcohol-associated liver disease
Appendicitis
Autoimmune hepatitis
Biliary colic
Bowel obstruction
Chronic cholecystitis
Chronic pyelonephritis
Chronic pancreatitis
Cirrhosis
Congenital disorders: Clinical
Crohn disease
Gastroesophageal reflux disease (GERD)
Irritable bowel syndrome
Lower urinary tract infection
Nephrotic syndromes: Pathology review
Peptic ulcer
Renal failure: Pathology review
Ulcerative colitis
Urinary tract infections: Pathology review
Viral hepatitis
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Skin cancer
Varicella zoster virus
Down syndrome (Trisomy 21)
Inheritance patterns
DNA damage and repair
DNA replication
Selective permeability of the cell membrane
Cell cycle
Free radicals and cellular injury
Autosomal trisomies: Pathology review
Breast cancer: Pathology review
Hypertension: Pathology review
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Peripheral artery disease
Pulmonary edema
Restrictive lung diseases
Stroke volume, ejection fraction, and cardiac output
Ventilation-perfusion ratios and V/Q mismatch
Cranial nerves
Migraine
Myasthenia gravis
Abnormal uterine bleeding: Clinical
Neisseria gonorrhoeae
Primary adrenal insufficiency
Benign prostatic hyperplasia
Hodgkin lymphoma
Introduction to the immune system
Celiac disease
Introduction to pharmacology
Drug administration and dosing regimens
Enzyme function
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Opioid antagonists
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Role of Vitamin K in coagulation
Vitamin B12 deficiency
Loop diuretics
Miscellaneous lipid-lowering medications
Potassium sparing diuretics
Adrenergic antagonists: Alpha blockers
Calcium channel blockers
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Adrenergic antagonists: Beta blockers
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class III antiarrhythmics: Potassium channel blockers
Class I antiarrhythmics: Sodium channel blockers
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Vaccinations
Anthelmintic medications
Anti-mite and louse medications
Antimalarials
Hepatitis medications
Integrase and entry inhibitors
Antimetabolites: Sulfonamides and trimethoprim
Azoles
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Echinocandins
Herpesvirus medications
Mechanisms of antibiotic resistance
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Neuraminidase inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Antihistamines for allergies
Miscellaneous antifungal medications
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
PDE5 inhibitors
Progestins and antiprogestins
Uterine stimulants and relaxants
Acid reducing medications
Antidiarrheals
Laxatives and cathartics
Non-corticosteroid immunosuppressants and immunotherapies
Hyperthyroidism medications
Hypoglycemics: Insulin secretagogues
Hypothyroidism medications
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Sympatholytics: Alpha-2 agonists
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Atypical antipsychotics
Atypical antidepressants
Typical antipsychotics
Lithium
Monoamine oxidase inhibitors
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Anti-parkinson medications
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Headaches: Clinical
Migraine medications
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Antigout medications
Folate (Vitamin B9) deficiency
Vitamin D
Fat-soluble vitamin deficiency and toxicity: Pathology review
Mumps virus
Measles virus
Rubella virus
Bordetella pertussis (Whooping cough)
Poliovirus
Pediatric infectious rashes: Clinical

Transcript

Watch video only

Every medication can be administered through various means, known as routes of administration; and various schedules, meaning at a particular frequency and amount, or dose, which is known as the dosing regimen.

Alright, so routes of administration are broken down into three main categories: enteral, parenteral, and topical. In enteral administration, which is the most common form, the medication is administered through the gastrointestinal tract. This could mean that it’s swallowed by the mouth, also known as peroral administration; placed under the tongue, also known as sublingual administration; between the gums and the inner lining of the cheek, also known as buccal administration; or finally, into the rectum, also known as rectal administration.

On the other hand, parenteral administration includes any route that bypasses the gastrointestinal tract, to pump the medication directly into the circulation, such as through an injection into a vein, intravenously, or IV for short; under the skin, subcutaneously, or SC for short; or into muscle, intramuscularly, or IM for short. Finally, there’s topical administration, where the medication is applied directly upon a particular area of the skin or mucous membrane to achieve a local or systemic effect. An example of this is an antifungal cream used to treat athlete's foot locally or a clonidine patch to treat hypertension systemically.

Now, choosing the route of administration depends on many factors. First of all, these include the chemical properties of the medication itself, such as its stability, and its ability to cross certain barriers of absorption.

For example, a perorally administered medication needs to be able to resist tough, acidic conditions within the stomach, and then readily pass through the walls of the intestines into the blood. In addition to this, blood coming from the gastrointestinal tract is first directed to the liver. And that’s where many medications get broken down or metabolized before gaining their entry ticket to the systemic circulation. This means the medications are metabolized before they even get a chance to reach their target tissues. This is known as first-pass metabolism or the first-pass effect.

So, medications that get extensively metabolized into inactive forms through that first-pass shouldn’t be administered perorally as it would decrease their efficacy. In contrast, IV administration allows medications that are less stable, or less capable of being absorbed through the gastrointestinal tract, to be directly administered into the bloodstream, which is also beneficial for medications that have a major first-pass effect.

A practical measure of absorption is bioavailability. Bioavailability refers to the portion of a medication that reaches the systemic circulation when administered by non-intravenous routes. For example, if someone takes 100 mg of aspirin orally, and only 60 mg are absorbed into the circulation, the bioavailability is 0.6 or 60%. In contrast, the bioavailability of an intravenously administered medication is always 1 or 100%.

Another factor that should be taken into account for deciding the route of administration is the urgency of the situation. So for example, peroral medications take time to get absorbed in the GI tract, so they produce an effect much slower than intravenous ones. And for this reason, intravenous administration is usually preferred in emergency settings and during surgical procedures. On the flip side, oral preparations are much easier to take at home and don’t need any special equipment.

Alright, now each medication is given at a specific schedule or dosing regimen, which determines the frequency of administration, or dosing interval, and the amount administered, known as dose. The regimen is important since it affects the onset of action, or the time it takes for a medication to start working and produce an effect, as well as the duration of action, which is the total length of time during which a medication produces an effect.

So, there are three main types of dosing regimens. First, there’s single dosing, meaning that only one dose of a medication is administered. Let’s plot this into a nice graph with the drug concentration in plasma on the y-axis, and the time on the x-axis. So, with single dosing, the plasma concentration of the medication rises steadily as it gets absorbed into the circulation, until it reaches a peak. Then the concentration drops again, as the medication is distributed into tissues, gets metabolized, and is eliminated.

Next, there’s a regimen of continuous infusion. This is when a medication is infused intravenously at a constant rate. In this case, the plasma concentration progressively rises and reaches a peak, but, instead of falling off, it continues at a plateau, also known as a steady state. The reason why this happens is that as the concentration of the medication increases, so does the rate of elimination, until eventually the dosing and the elimination rate are equal.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Administration of substances to laboratory animals: routes of administration and factors to consider" J Am Assoc Lab Anim Sci (2011)
  4. "Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals" Pharmaceutics (2019)
  5. "Pharmaceutically Used Polymers: Principles, Structures, and Applications of Pharmaceutical Delivery Systems" Drug Delivery (2009)
  6. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)